General Chemical Properties COA IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 (IGF-1), modified with an extended amino acid sequence to enhance biological activity and increase stability
Always be open and honest with your healthcare provider to ensure the best possible outcomes when taking this medication
The box will have a label with your name, the name of the medication, and your healthcare providers information
Your individual response depends on factors like your starting dose, how quickly it was increased, and your baseline gastrointestinal sensitivity
Unge, A., Tombolini, R., Molbak, L
Other notable adverse effects include injection site reactions, fatigue, and hypoglycemia (particularly in patients taking concomitant insulin or insulin secretagogues)